The company will manufacture and market the tablets used for treating erectile dysfunction and pulmonary arterial hypertension
Aurobindo Pharma has crossed the first line, receiving a tentative approval from the US Food and Drug Administration a temporary nod to manufacture and market its drug , Sildenafil Citrate. The status quo is a tentative nod for the company to produce 25 mg, 50 mg, and 100 mg of the considered tablet.Viagra is the brand name for Sildenafil Citrate.
As the name suggests, the drug is used to treat erectile dysfunction and pulmonary arterial hypertension. Aurobindo Pharma is a leading name in the Indian pharmaceutical industry with a sound product portfolio comprising CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic. The company also has its manufacturing facilities duly inspected by the USFDA as per the standard norms followed by the regulator.